Pramipexole Immediate Release

( DrugBank: Pramipexole / KEGG DRUG: Pramipexole )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	9

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 9 of 9 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03521635 (ClinicalTrials.gov)	July 3, 2018	11/4/2018	The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexoleon the noctUrna ...	A Two- Stage Multicenter, Open-label, Randomized, Active Controlled Parallel Group Study Comparing t ...	Parkinson Disease	Drug: Pramipexole SR;Drug: Pramipexole IR	Boehringer Ingelheim	NULL	Completed	30 Years	N/A	All	98	Phase 4	China
2	NCT01191944 (ClinicalTrials.gov)	August 2010	30/8/2010	PramipexoleExtended ReleaseVersus Pramipexole Immediate Releasefor 18 Weeks in Chinese Parkinson's D ...	A Double-blind, Double-dummy, Randomised, Parallel-group Study Comparing the Efficacy, Safety and To ...	Parkinson Disease	Drug: pramipexole immediate release tablet;Drug: pramipexole extended release tablet	Boehringer Ingelheim	NULL	Completed	30 Years	N/A	All	475	Phase 3	China
3	EUCTR2009-015833-66-IT (EUCTR)	20/01/2009	18/04/2012	Ropinirole 24h prolonged releaseand motor fluctuations: a study to control the wearing-off induced b ...	Ropinirole 24h prolonged releaseand motor fluctuations: a study to control the wearing-off induced b ...	Parkinson's Disease MedDRA version: 14.1;Level: LLT;Classification code 10013113;Term: Disease Parki ...	Trade Name: REQUIP*28CPR 8MG R.P. INN or Proposed INN: ROPINIROLE Other descriptive name: NA Trade Name ...	CASA DI CURA PRIVATA S.RAFFAELE - PISANA	NULL	Not Recruiting			Female: yes Male: yes			Italy
4	NCT00651183 (ClinicalTrials.gov)	April 2008	31/3/2008	Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under PramipexoleTr ...	Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under PramipexoleTr ...	Parkinson Disease	Drug: Pramipexole immediate release	Boehringer Ingelheim	NULL	Completed	18 Years	N/A	All	286		Austria
5	NCT00560508 (ClinicalTrials.gov)	November 2007	16/11/2007	A 12-week Study of PramipexoleExtended Release(ER) in Patients With Parkinson's Disease (PD), Follow ...	A Double-blind, Double-dummy, Randomised, Parallel-group Study to Investigate the Safety, Tolerabili ...	Parkinson Disease	Drug: Pramipexole Immediate Release;Drug: Pramipexole Extended Release	Boehringer Ingelheim	NULL	Completed	1 Year	N/A	All	112	Phase 2/Phase 3	Japan
6	NCT00558025 (ClinicalTrials.gov)	October 2007	12/11/2007	Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease	A Double-blind, Double-dummy, Randomized, Parallel Groups Study to Assess the Efficacy, Safety and T ...	Parkinson Disease	Drug: Pramipexole Extended Release;Drug: Pramipexole Immediate Release	Boehringer Ingelheim	NULL	Completed	30 Years	N/A	All	156	Phase 3	France;Germany;Netherlands
7	NCT00479401 (ClinicalTrials.gov)	May 2007	25/5/2007	Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Pati ...	A Double-blind, Double-dummy, Placebo-controlled, Randomized, Three Parallel Groups Study Comparing ...	Early Parkinson Disease (Early PD)	Drug: Pramipexol Extended Release;Drug: Pramipexol Immediate Release;Drug: Placebo	Boehringer Ingelheim	NULL	Completed	30 Years	N/A	All	539	Phase 3	United States;Argentina;Austria;Czech Republic;Finland;Germany;Hungary;India;Japan;Malaysia;Russian ...
8	NCT00466167 (ClinicalTrials.gov)	April 2007	25/4/2007	Pivotal Study in Advanced Parkinsons Disease Patients	A Double-blind, Double-dummy, Placebo-controlled, Randomized, Three Parallel Groups Study Comparing ...	Parkinson Disease	Drug: Pramipexol Extended Release;Drug: Pramipexol Immediate Release;Drug: Placebo	Boehringer Ingelheim	NULL	Completed	32 Years	N/A	All	517	Phase 3	Austria;Czech Republic;Hungary;India;Italy;Korea, Republic of;Philippines;Poland;Russian Federation; ...
9	NCT00144300 (ClinicalTrials.gov)	January 2005	2/9/2005	Ophthalmologic Safety Study of Pramipexole Immediate Release(IR) Versus Ropinirole in Early Parkinso ...	A Two Year Open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study of ...	Parkinson Disease	Drug: Mirapex;Drug: Requip	Boehringer Ingelheim	NULL	Completed	30 Years	N/A	All	246	Phase 4	United States

First Previous1Next Last